What is LOPJLB’s current signal on AVTX?

LOPJLB’s latest quantitative signal on Avalo Therapeutics, Inc. (AVTX) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is AVTX in?

Avalo Therapeutics, Inc. (AVTX) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Avalo Therapeutics, Inc. (AVTX) do?

Avalo Therapeutics, Inc. is a precision medicine company in the clinical development phase, dedicated to identifying, advancing, and marketing specialized treatments for patients experiencing critical unmet medical needs across the fields of immunology, immuno-oncology, and rare genetic disorders. Among its key pipeline assets is AVTX-002, a fully human monoclonal antibody designed to inhibit L…